Clinical Trial Details
| Trial ID: | L0436 |
| Source ID: | NCT00776191 |
| Associated Drug: | Physioneal 35 |
| Title: | Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism |
| Acronym: | NephropaedPD01 |
| Status: | TERMINATED |
| Study Results: | NO |
| Results: | |
| Conditions: | Endstage Renal Disease |
| Interventions: | DRUG: Physioneal 35|DRUG: Physioneal 40 |
| Outcome Measures: | Primary: To demonstrate an increase in protein metabolism during treatment with Physioneal 35® compared to treatment with Physioneal 40® in children and adolescents with end stage renal failure receiving peritoneal dialysis., 16 weeks | Secondary: To demonstrate a improved Fat oxidation during treatment with Physioneal compared to treatment with Physioneal 40® in children and adolescents with end stage renal failure receiving peritoneal dialysis., 16 weeks |
| Sponsor/Collaborators: | Sponsor: University of Erlangen-Nürnberg Medical School |
| Gender: | ALL |
| Age: | CHILD, ADULT |
| Phases: | PHASE4 |
| Enrollment: | 5 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2008-09 |
| Completion Date: | 2012-05 |
| Results First Posted: | |
| Last Update Posted: | 2015-06-04 |
| Locations: | Pediatric Nephrology, Universiy Children's Hospital, Cologne, Germany|Dept. of Pediatric Nephrology, University Hospital Erlangen, Erlangen, Germany|Dept. of Pediatric Nephrology, University of Hannover, Hannover, 30625, Germany|Dept. of Nephrology, children´s hospital Memmingen, Memmingen, 87700, Germany|Dept. of Nephrology, University of Rostock, Rostock, 18057, Germany |
| URL: | https://clinicaltrials.gov/show/NCT00776191 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|